~~<i id='E07E4954D2'><strike id='E07E4954D2'><tt id='E07E4954D2'><pre id='E07E4954D2'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：entertainment 2025-10-04 12:15:59 Page View：15129

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What to watch for from Zogenix and Amicus clinical trials
Next article： Hollywood unions extend contract negotiations for actors

explore

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

PhRMA sues HHS over Medicare drug price negotiation

PhRMAissuingtheBidenadministrationoveritsnewMedicaredrugpricenegotiationprogram.GraemeSloan/SipaUSAW

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

These geoengineering technologies could help combat the climate crisis, scientists say

5:11InthisFeb.1,2023,filephoto,apieceofequipmentcalledadistributorusedtoholdtraysoflimestoneforcaptu